Chul-Woo Jung
Papers
1
Total Citations
8
H-Index
1
About
Dr. Chul-Woo Jung is a leading anesthesiologist whose research focuses on perioperative pain management and anesthetic pharmacology, particularly the nuanced effects of remifentanil during total intravenous anesthesia (TIVA). His most-cited work, a 2018 study on robotic thyroid surgery, demonstrates a critical contribution: it challenges prevailing assumptions by revealing that excessive remifentanil during TIVA is paradoxically associated with an increased risk of postoperative pain. This finding, which has garnered 8 citations, provides essential clinical guidance for optimizing opioid dosing to prevent remifentanil-induced hyperalgesia. Dr. Jung’s research directly impacts surgical safety and patient recovery, offering evidence-based strategies to balance intraoperative anesthesia with long-term comfort. His work is particularly notable for its focus on robotic thyroid procedures, a technically demanding field where precise anesthetic management is vital. By identifying the risks of high-dose remifentanil even within TIVA protocols, Dr. Jung has advanced the understanding of opioid pharmacology and refined perioperative care standards, making him a respected voice in anesthesiology research.
Research Focus
Key Achievements
Top Papers
- 1